600513.SHG Jiangsu Lianhuan Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
13.19 CNY
Close of Nov 4, 2026
12.27 32.27
Market cap
CNY 3.77B
P/E
-
P/B
2.86x
ROE
1.3%
Dividend yield
1.34%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is 600513.SHG undervalued?

Graham number

The Graham number of Jiangsu Lianhuan Pharmaceutical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jiangsu Lianhuan Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Jiangsu Lianhuan Pharmaceutical Co Ltd yet.

Jiangsu Lianhuan Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jiangsu Lianhuan Pharmaceutical Co Ltd

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, dapoxetine hydrochloride, milrinone injection, aprilite, ebastine tablets, felodipine tablets, tadalafil, and betasine besylate tablets, as well as danazol suppositories, drapa…

Full company profile